journal article·2025-08-27

Metabolic Hijacking: An MOF-Based Nanoprogrammer Overcomes Drug Resistance in Glioblastoma

Xiuyan Wan, Huiwen Zhang, Linzong Xu, Wei Pan, Jie Zhang, Liqun Song, Yingchao Liu, Na Li, Bo Tang

Nano Letters· Volume 25· Issue 34
Publisher page

Abstract

Glioblastoma (GBM) is one of the deadliest solid cancers with limited treatment options. Resistance to Temozolomide (TMZ), the most common oral anticancer drug available for GBM, develops rapidly and frequently in patients. This study reveals TMZ-sensitive GBM cells rely on glycolysis, while resistant counterparts preferentially utilize fatty acid oxidation (FAO). Hence, we developed an engineered nanoprogrammer using a metal–organic framework (MOF) coloaded with TMZ and the FAO inhibitor (etomoxir, ETO). Postengineered unsaturated Fe 3+ sites adsorbed transferrin, enabling efficient blood–brain barrier traversal and tumor targeting. TMZ suppressed aggressive tumor growth by eliminating glycolysis-dependent cells during early treatment. Simultaneously, ETO inhibited FAO in resistant cells, forcing metabolic rewiring to glycolysis and restoring TMZ susceptibility. This dual-action strategy disrupted energy pathways in heterogeneous tumors, overcoming resistance. The nanoprogrammer demonstrated potent efficacy in orthotopic and patient-derived drug-resistant GBM models, achieving significant tumor suppression without notable toxicity.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Glioma Diagnosis and Treatment · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Institute of Molecular and Nano Science

Shandong Normal University

Tumor Research and Therapy Center, Shandong Provincial Hospital

Shandong University

Department of Neurosurgery

Provincial Hospital Affiliated to Shandong First Medical University

Laoshan Laboratory

Funding

National Natural Science Foundation of China · Natural Science Foundation of Shandong Province · Fundamental Research Funds of Shandong Province · Youth Innovation Science and Technology Program of Higher Education Institution of Shandong Province · Natural Science Foundation of Shandong Province (Major Basic Research Project)

References (33)

Show source-provided references
1. 10.1016/j.cell.2021.04.00810.1016/j.cell.2021.04.008 ↗
2. 10.1021/acs.nanolett.4c0022310.1021/acs.nanolett.4c00223 ↗
3. 10.1038/s43018-021-00267-910.1038/s43018-021-00267-9 ↗
4. 10.1038/s41586-022-05551-x10.1038/s41586-022-05551-x ↗
5. 10.1021/acs.nanolett.4c0547010.1021/acs.nanolett.4c05470 ↗
6. 10.1038/s41565-020-00843-710.1038/s41565-020-00843-7 ↗
7. 10.1038/ng.359010.1038/ng.3590 ↗
8. 10.1158/1078-0432.CCR-12-003910.1158/1078-0432.CCR-12-0039 ↗
9. 10.1056/NEJMoa04333010.1056/NEJMoa043330 ↗
10. 10.1007/s11060-020-03561-110.1007/s11060-020-03561-1 ↗
11. 10.1038/s41467-023-41663-210.1038/s41467-023-41663-2 ↗
12. 10.1073/pnas.110670410810.1073/pnas.1106704108 ↗
13. 10.1101/gad.188292.11210.1101/gad.188292.112 ↗
14. 10.1038/s41586-019-0993-x10.1038/s41586-019-0993-x ↗
15. 10.15252/embj.20179877210.15252/embj.201798772 ↗
16. 10.1038/s41401-022-00984-610.1038/s41401-022-00984-6 ↗
17. 10.1038/nrc348310.1038/nrc3483 ↗
18. 10.1021/acs.nanolett.3c0350910.1021/acs.nanolett.3c03509 ↗
19. 10.1038/nmat377610.1038/nmat3776 ↗
20. 10.1021/acsnano.7b0696910.1021/acsnano.7b06969 ↗
21. 10.1002/anie.20200747410.1002/anie.202007474 ↗
22. Peacock M. · 2015 · 45510.1016/B978-0-12-397166-1.00031-X ↗
23. 10.1016/S0304-4157(96)00014-710.1016/S0304-4157(96)00014-7 ↗
24. 10.1016/0098-2997(81)90003-010.1016/0098-2997(81)90003-0 ↗
25. 10.1038/onc.2010.21510.1038/onc.2010.215 ↗
26. 10.1002/emmm.20130282710.1002/emmm.201302827 ↗
27. 10.1158/1078-0432.CCR-11-328110.1158/1078-0432.CCR-11-3281 ↗
28. 10.1074/jbc.M110.12180610.1074/jbc.M110.121806 ↗
29. 10.1016/j.celrep.2014.08.05610.1016/j.celrep.2014.08.056 ↗
30. 10.1371/journal.pone.005211310.1371/journal.pone.0052113 ↗
31. 10.1038/s41467-019-10592-410.1038/s41467-019-10592-4 ↗
32. 10.1093/neuonc/now12810.1093/neuonc/now128 ↗
33. 10.1038/sj.cdd.440163610.1038/sj.cdd.4401636 ↗